Mangalam Drugs & Organics Limited

BSE:532637 Stock Report

Market Cap: ₹1.8b

Mangalam Drugs & Organics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 532637?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3,829,97024.2%
Private Companies5,116,69232.3%
General Public6,881,58643.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 20 shareholders own 56.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.7%
Shri JB Pharma Private Limited
2,650,000₹304.4m0%no data
6.94%
Shree Kishoriju Trading & Investment Pvt. Ltd.
1,098,515₹126.2m0%no data
6.81%
Govardhan Dhoot
1,077,122₹123.7m0%no data
6.39%
Shree Rasbihari Trading and Investment Pvt Ltd.
1,011,663₹116.2m0%no data
3.57%
Brijmohan Dhoot
564,469₹64.8m0%no data
1.91%
Ashutosh Taparia
302,000₹34.7m0%no data
1.9%
Ajay Upadhyaya
300,000₹34.5m0%no data
1.85%
Radhika Dhoot
292,500₹33.6m0%no data
1.85%
Smita Dhoot
292,500₹33.6m0%no data
1.74%
Rajkumari Dhoot
275,948₹31.7m0%no data
1.33%
Jyotiprasad Taparia
211,291₹24.3m0%no data
1.21%
Raj Exports Pvt Ltd
191,520₹22.0m0%no data
1.04%
Ambika Food Industries Private Limited
164,994₹18.9m0%no data
0.93%
Rekha Dhoot
146,760₹16.9m-1.34%no data
0.88%
Ajay Dhoot
138,687₹15.9m0%no data
0.66%
Jyoti Dhoot
104,550₹12.0m0%no data
0.56%
Aditya Dhoot
89,225₹10.2m0%no data
0.18%
Rajkamal Sukhani
28,520₹3.3m0%no data
0.04%
Yaduraj Dhoot
6,331₹727.1k0%no data
0.00042%
Chandrakanta Dhoot
67₹7.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mangalam Drugs & Organics Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vijay MadunalaFirstCall Research